Contact
searchSearch
HMP Global

Advertisement

ADVERTISEMENT

Venous Disease: Features

Thermal Imaging Positioned to Become the Best Tool in the Evaluation of Superficial Venous Insufficiency
Editor's Corner
Thermal Imaging Positioned to Become the Best Tool in the Evaluation of Superficial Venous Insufficiency
03/04/2021
Dr. Walker comments on Dr. Ariel Soffer and colleagues’ article “Sensitivity and Specificity of Thermal Imaging When Used to Detect Superficial Venous Reflux as Compared to Duplex Ultrasound.”
Dr. Walker comments on Dr. Ariel Soffer and colleagues’ article “Sensitivity and Specificity of Thermal Imaging When Used to Detect Superficial Venous Reflux as Compared to Duplex Ultrasound.”
Dr. Walker comments on Dr. Ariel...
03/04/2021
Vascular Disease Management
Case Report
Endovascular Treatment of Superior Vena Cava Syndrome
02/16/2021
Superior vena cava syndrome represents a partial or total obstruction of the superior vena cava. The obstruction may be acute or chronic.
Superior vena cava syndrome represents a partial or total obstruction of the superior vena cava. The obstruction may be acute or chronic.
Superior vena cava syndrome...
02/16/2021
Vascular Disease Management
Case Report
A Curious Case of Hypercoagulability
01/13/2021
Peripheral artery disease and coronary artery disease are the onset of arterial occlusions leading to symptoms associated with claudication and angina, respectively.
Peripheral artery disease and coronary artery disease are the onset of arterial occlusions leading to symptoms associated with claudication and angina, respectively.
Peripheral artery disease and...
01/13/2021
Vascular Disease Management
Original Research
Thermal Imaging of Superficial Leg Circulation Improves Venous Diagnostic Efficiency and Completeness
11/18/2020
The impact of thermal imaging of legs was assessed by comparing complete duplex ultrasound diagnostic results before and after thermal imaging.
The impact of thermal imaging of legs was assessed by comparing complete duplex ultrasound diagnostic results before and after thermal imaging.
The impact of thermal imaging of...
11/18/2020
Vascular Disease Management
The Potential of Thermography as a Practical Screening Tool for Superficial Venous Insufficiency
Editor's Corner
The Potential of Thermography as a Practical Screening Tool for Superficial Venous Insufficiency
11/18/2020
Dr. Walker comments on “Thermal Imaging of Superficial Leg Circulation Improves Venous Diagnostic Efficiency and Completeness.”
Dr. Walker comments on “Thermal Imaging of Superficial Leg Circulation Improves Venous Diagnostic Efficiency and Completeness.”
Dr. Walker comments on “Thermal...
11/18/2020
Vascular Disease Management
Case Report
A Very High-flow Arteriovenous Fistula With Added Bleeding Risk: One Solution for Two Problems
09/15/2020
Native arteriovenous fistula is considered the gold standard of vascular access for hemodialysis due to higher patency rates and fewer complications.
Native arteriovenous fistula is considered the gold standard of vascular access for hemodialysis due to higher patency rates and fewer complications.
Native arteriovenous fistula is...
09/15/2020
Vascular Disease Management
Original Research
Optimal Hemodialysis Arteriovenous Fistula Flow Volume for Cardiovascular Safety
08/20/2020
AVFs have become the gold standard for patients with chronic renal failure who require chronic hemodialysis since 1966 when Brescia and associates constructed a fistula between the radial artery and the cephalic vein.
AVFs have become the gold standard for patients with chronic renal failure who require chronic hemodialysis since 1966 when Brescia and associates constructed a fistula between the radial artery and the cephalic vein.
AVFs have become the gold...
08/20/2020
Vascular Disease Management
Case Series
Clinical Pearls for Management of Postoperative Deep Vein Arterialization Patients Following Lower Extremity Minor Amputation: A Case Series
07/08/2020
CLI is the end stage of PAD and occurs in 1% to 3% of PAD patients. Patients commonly present with life-changing symptoms such as severe rest pain, ulcers, or gangrenous changes and reduced quality of life.
CLI is the end stage of PAD and occurs in 1% to 3% of PAD patients. Patients commonly present with life-changing symptoms such as severe rest pain, ulcers, or gangrenous changes and reduced quality of life.
CLI is the end stage of PAD and...
07/08/2020
Vascular Disease Management
Deep Vein Arterialization Shows Great Promise in "No Option" Patients
Editor's Corner
Deep Vein Arterialization Shows Great Promise in "No Option" Patients
07/08/2020
Dr. Walker comments on "Clinical Pearls for Management of Postoperative Deep Vein Arterialization Patients Following Lower Extremity Minor Amputation" by podiatrists Michael Brown and Guy Pupp.
Dr. Walker comments on "Clinical Pearls for Management of Postoperative Deep Vein Arterialization Patients Following Lower Extremity Minor Amputation" by podiatrists Michael Brown and Guy Pupp.
Dr. Walker comments on "Clinical...
07/08/2020
Vascular Disease Management
Angiography Post Wallstent Implantation in the Inferior Vena Cava
VIdeo
Angiography Post Wallstent Implantation in the Inferior Vena Cava
04/20/2020
Post Wallstent implantation angiography demonstrating excellent flow in both left and right common iliac vein stents.
Post Wallstent implantation angiography demonstrating excellent flow in both left and right common iliac vein stents.
Post Wallstent implantation...
04/20/2020
Vascular Disease Management

Advertisement

Advertisement

Stay in the Know

Vascular Disease Management Newsletter

Advertisement

Advertisement

News

First Aid guidelines
AHA/American Red Cross: Updated First Aid Guidelines Enhance Care for Opioid Overdose, Bleeding, Other Emergencies
11/14/2024
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major comprehensive updates to the first aid guidelines since 2010 and address shifts in how the public manages common and critical first aid emergencies.
These are the first major...
11/14/2024
Cath Lab Digest
Late-Breaking Trials
Final Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/06/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the final round of Late-Breaking Clinical Trials presented at...
The VIVA Foundation, a...
11/06/2024
Vascular Disease Management
Late-Breaking Trials
Third Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/05/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the third of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/05/2024
Vascular Disease Management
Late-Breaking Trials
Second Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the second of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Late-Breaking Trials
First Round of Late-Breaking Clinical Trial Results Announced at VIVA24
11/04/2024
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the results for the first of four rounds of Late-Breaking Clinical Trials...
The VIVA Foundation, a...
11/04/2024
Vascular Disease Management
Image-Guided Therapy
Philips Enrolls First Patient in U.S. Clinical Trial for Innovative Integrated Single-Device to Treat Peripheral Artery Disease
11/04/2024
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first ability to perform laser atherectomy and laser-based intravascular lithotripsy using a single device, Philips takes a major step forward in the treatment of peripheral artery disease (PAD) Cardiovascular...
With a unique world-first...
11/04/2024
Vascular Disease Management
Pulmonary Embolism
Akura Medical Secures FDA Approval for US Pivotal Trial in Pulmonary Embolism
11/04/2024
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate the safety and effectiveness of the Katana™ Thrombectomy System LOS GATOS, Calif., Nov. 4, 2024 /PRNewswire/ -- Akura Medical, a Shifamed portfolio company focused on reshaping the...
QUADRA-PE study will evaluate...
11/04/2024
Vascular Disease Management
Peripheral Arterial Disease
FDA Grants R3 Vascular IDE Approval for ELITE-BTK Pivotal Trial of its MAGNITUDE® Drug Eluting Next Generation Bioresorbable Scaffold for Below-the-Knee Peripheral Arterial Disease
11/04/2024
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November 4, 2024 – R3 Vascular Inc., a medical device company dedicated to developing and providing novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), is pleased to announce...
MOUNTAIN VIEW, Calif. – November...
11/04/2024
Vascular Disease Management
Patient Awareness
Baby Boomers Beware: More Americans Than Ever Before Now at Higher Risk for Common Blood Vessel Diseases
10/31/2024
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in three Americans at highest risk for blood vessel diseases and life-threatening complications report low awareness Society for Vascular Surgery launches the Highway to Health campaign to help people maintain...
New survey reveals nearly one in...
10/31/2024
Vascular Disease Management
DCB
SIRONA Trial @TCT – First Head-to-Head Comparison of Sirolimus Versus Paclitaxel DCBs in the Treatment of PAD: Sirolimus-Coated Balloons Yield Similar Results to Paclitaxel-Coated Balloons in the Femoropopliteal Artery
10/30/2024
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective, multicenter, investigator-initiated SIRONA randomized clinical trial demonstrated MagicTouch™️ sirolimus-coated balloons to be noninferior compared to paclitaxel-coated balloons with regards to the primary safety...
Data from the prospective,...
10/30/2024
Cath Lab Digest

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use

Advertisement

Advertisement